학술논문
Update to the Direct-to-Consumer Debate: The Risks and Benefits of Pharmaceutical Promotion Across the Atlantic.
Document Type
Article
Author
Source
Subject
*Pharmaceutical industry
*Public relations
*Medical care
Drug advertising
Drugs
*
*
Language
ISSN
1082-9113
Abstract
Discusses the risks and benefits of direct-to-consumer (DTC) pharmaceutical promotion in Europe. Practice of DTC pharmaceutical promotion in the United States; Tools that health care public relations practitioners in Europe employ to promote products and services; European Commission's proposal to review European Union pharmaceutical legislation to ensure better dissemination of pharmaceutical information to the public.